Clinuvel Pharmaceuticals to Prioritize Programs With Highest Likelihood of Regulatory Approval, Commercial Success
Clinuvel Pharmaceuticals to Prioritize Programs With Highest Likelihood of Regulatory Approval, Commercial Success
Clinuvel製藥公司將優先考慮最有可能獲得監管批准和商業成功的項目
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間